MDxHealth
MDXH
5 hedge funds and large institutions have $24.7M invested in MDxHealth in 2022 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 1 closing their positions.
1% more capital invested
Capital invested by funds: $24.5M → $24.7M (+$151K)
0% more funds holding
Funds holding: 5 → 5 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.22% less ownership
Funds ownership: 19.25% → 19.03% (-0.22%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$14.6K |
| 2 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$3.54K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$306K |
MDXH Hedge Fund Activity: Q2 2022 in Review
5 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in MDxHealth (MDXH) for Q2 2022, worth a combined $24.7M — up 0.61% from $24.5M a quarter earlier.
Fund positioning in MDXH was balanced in Q2 2022: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was UBS Group, adding an estimated $14.6K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $306K sold.
- 5 institutional investors held MDxHealth (MDXH) as of Q2 2022, unchanged from Q1 2022.
- Funds reported $24.7M of MDxHealth stock for Q2 2022, up 0.61% quarter-over-quarter.
- 1 fund opened new MDxHealth positions in Q2 2022 and 1 closed out, a net change of 0 holders.
- The largest MDxHealth buyer in Q2 2022 was UBS Group, an estimated $14.6K added.
- The largest MDxHealth seller in Q2 2022 was Hudson Bay Capital Management, an estimated $306K sold.
Based on aggregated 13F filings for Q2 2022.